Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126234471 | 12623447 | 1 | I | 201506 | 20160721 | 20160804 | 20160804 | PER | US-BAYER-2016-145160 | BAYER | 57.00 | YR | A | F | Y | 0.00000 | 20160804 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126234471 | 12623447 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | UNK | Y | 103471 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | |||||||||
| 126234471 | 12623447 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | BID | |||||||
| 126234471 | 12623447 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | 10 MG, BID | 000079809 | 0 | 10 | MG | BID | |||||||
| 126234471 | 12623447 | 4 | SS | COPAXONE | GLATIRAMER ACETATE | 1 | Parenteral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 126234471 | 12623447 | 5 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 126234471 | 12623447 | 6 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 126234471 | 12623447 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 126234471 | 12623447 | 8 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 126234471 | 12623447 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126234471 | 12623447 | 2 | Multiple sclerosis |
| 126234471 | 12623447 | 3 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126234471 | 12623447 | Emotional distress | |
| 126234471 | 12623447 | Injection site mass | |
| 126234471 | 12623447 | Injection site pain | |
| 126234471 | 12623447 | Injection site reaction | |
| 126234471 | 12623447 | Muscle fatigue | |
| 126234471 | 12623447 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126234471 | 12623447 | 1 | 201205 | 0 | ||
| 126234471 | 12623447 | 2 | 201506 | 0 | ||
| 126234471 | 12623447 | 4 | 20160328 | 0 |